Valmore Technologies is a dynamic software development and integration company founded in 2020, bringing together a team of 25 highly skilled engineers, architects, and domain experts. Our core strength lies in designing and delivering scalable, future-proof digital solutions across web, mobile, and cloud platforms. With extensive experience in system integration, data engineering, and AI, Valmore has become a trusted partner for organizations seeking to modernize their operations and unlock the value of their data. Central to our philosophy is a relentless commitment to delivery, ensuring that every project we undertake balances innovation with reliability.
A strong area of focus for Valmore is eHealth, where we combine technology innovation with societal impact. Our flagship project, Hyfense, is an intelligent software platform designed to address two of the most pressing healthcare challenges today: antimicrobial resistance (AMR) and hospital-acquired infections (HAI). Developed with the support of national funding and in collaboration with leading healthcare institutions and one of the country’s foremost infection specialists, Hyfense leverages advanced analytics, interoperability standards (HL7/FHIR), and clinical decision support tools to assist hospitals in monitoring, preventing, and responding to infections in real time. By enabling evidence-based insights and integrating seamlessly with hospital information systems, Hyfense empowers healthcare professionals to make faster, safer, and more informed decisions. For Valmore, Hyfense represents not only a breakthrough product but also our broader vision: to harness the power of software engineering, AI, and data to improve public health outcomes, support medical research, and enhance the resilience of healthcare systems worldwide.